National Institutes of Health
Improved Drug Susceptibility Testing (DST) for Mycobacteria
Improved Drug Susceptibility Testing (DST) for Mycobacteria is a funding opportunity from National Institutes of Health, closing May 28, 2027.
May 28, 2027
(301d left)Overview
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by supporting research to develop improved drug susceptibility tests (DSTs) for mycobacterial drugs, including those currently used for treatment of tuberculosis (TB) and clinically important non-tuberculous…